Glycans in Vaccine Development

Glycans are at the core of many disorders and diseases generating the chance of exploiting them for therapeutic and diagnostic purposes. There are many biochemical paths and diseases in which glycans are intricately involved. Evaluating the huge potential and the capacity that glycobiology holds, many pharma and biotech companies have already started assigning their R&D budget to it. Currently, with our drug resource fast depleting against drug resistant and mutant pathogens, glycobiology hold an intact source of new candidate drugs.

  • Glycoconjugate vaccines
  • Drug interaction in cellular networking
  • Bio-defense vaccine
  • Microbial glycobiology
  • Glycoengineering

Glycans in Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in